Nitin Jain, MD | Authors

Articles

Lymphodepletion Improves Results for Allogenic CAR T-Cell Therapy in ALL

January 07, 2022

Nitin Jain, MD, discusses the preliminary results of a study investigating allogeneic chimeric antigen receptor T-cell therapy with lymphodepletion in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

An Overview of a Study Combining Nivolumab With Ibrutinib in CLL and Richter Transformation

December 06, 2016

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses a phase II trial combining nivolumab (Opdivo) with ibrutinib (Imbruvica) for chronic lymphocytic leukemia (CLL) and richter transformation (RT) during the American Society of Hematology (ASH) Annual Meeting.